Back to top
 
INDICATOR NAME
Name
Percentage of Ontario screen-eligible women who completed at least one Pap test in 42-month period QIP (Retired)
Alternate Name
Percentage of Ontario screen-eligible women, 21-69 years old, who completed at least one Pap test in 42-month period QIP
 
INDICATOR DESCRIPTION
Description
This indicator measures the percentage of Ontario screen-eligible women, 21-69 years old, who completed at least one Pap test in 42-month period.
Indicator Status
Active
HQO Reporting tool/product
Quality Improvement Plans (QIPs)
Dimension
Equitable
Type
Outcome
 
DEFINITION AND SOURCE INFORMATION
Unit of Measurement
Percentage
Calculation Methods
Percentage is calculated as: numerator divided by denominator times 100.
Numerator including inclusion/exclusion
 Total number of Ontario screen-eligible women, 21-69 years old, who have completed at least one Pap test in a 42 month time frame
  • Identifying Pap tests:

Pap tests were identified through CytoBase

Pap tests were also identified using fee codes in OHIP:

           -E430A: add-on to a003, a004, a005, a006 when pap performed outside hospita

           -G365A: Periodic-pap smear

           -E431A:  When Papanicolaou smear is performed outside of hospital, to G394. 

           -G394A: Additional for follow-up of abnormal or inadequate smears

           -L713A: Lab.med.-anat path,hist,cyt-cytol-gynaecological specimen

           -L733A: Cervicovaginal specimen (monolayer cell methodology)

           -L812A: Cervical vaginal specimens including all types of cellular abnormality, assessment of flora, and/or                   cytohormonal evaluation

           -Q678A: Gynaecology – pap smear – periodic – nurse practitioners

           -L643A:Lab Med - Microbiol - Microscopy - Smear Only, Gram/Pap Stain

  • All Pap tests in CytoBase were counted, including those with inadequate specimens

           -Each woman was counted once regardless of the number of Pap tests performed in a 42 month time frame


Denominator including inclusion/exclusion

Total number of Ontario screen-eligible women, 21-69 years old, in the reporting period

  • Ontario screen-eligible women aged 21-69 at the index date
  • Index date was defined as the midpoint in a reporting period, e.g. July 1st 2014 for 2013-2015
  • The 2011 Canadian population was used as the standard population for calculating age-standardized rates
  • The RPDB address closest to the index date was used to assign postal code
  • LHIN assignment was determined using PCCF+, version 6C; residential postal code was used to identify LHIN and individuals with unknown/missing LHINs were excluded from the analysis
  • Public health unit data was determined using PCCF+, version 6C

Exclusions:

  • Women with a missing or invalid HIN, date of birth, LHIN or postal code
  • Women diagnosed with an invasive cervical cancer prior to January 1st of  the reporting period, e.g. January 1st 2013 for 2013-2015; prior diagnosis of cervical cancer was defined as: ICD-O-3 codes C53, a morphology indicative of cervical cancer, microscopically confirmed with a path report
  • Women who had a colposcopy and/or treatment within 2 years prior to January 1st of the reporting period Colposcopy and/or treatment were identified through OHIP, using the following fee codes:
    • Colposcopy
      • Z731 - Initial investigation of abnormal cytology of vulva and/or vagina or cervix under colposcopic technique with or without biopsy(ies) and/or endocervical curetting
      • Z787 - Follow-up colposcopy with biopsy(ies) with or without endocervical curetting
      • Z730 - Follow-up colposcopy without biopsy with or without endocervical curetting
    • Treatment
      • Z732 - Cryotherapy
      • Z724 - Electro
      • Z766 - Electrosurgical Excision Procedure (LEEP)
      • S744 - Cervix - cone biopsy - any technique, with or without D&C
      • Z720 - Cervix Biopsy - with or without fulguration
      • Z729 - Cryoconization, electroconization or CO2 laser therapy with or without curettage for premalignant lesion (dysplasia or carcinoma in-situ), out-patient procedure
  • Women with a hysterectomy prior to January 1st of the reporting period, e.g. January 1st 2013 for 2013-2015
  • Women with a hysterectomy were identified through CHDB, using the following fee codes:
    • E862A – When hysterectomy is performed laparoscopically, or with laparoscopic assistance
    • P042A – Obstetrics – labour – delivery – caesarean section including hysterectomy
    • Q140A – Exclusion code for enrolled female patients aged 35-70 with hysterectomy
    • S710A – Hysterectomy - with or without adnexa (unless otherwise specified)  – with omentectomy for malignancy
    • S727A – Ovarian debulking for stage 2C, 3B or 4 ovarian cancer and may include hysterectomy
    • S757A – Hysterectomy – with or without adnexa (unless otherwise specified) – abdominal – total or subtotal
    • S758A – Hysterectomy - with or without adnexa (unless otherwise specified) – with anterior and posterior vaginal repair and including enterocoele and/or vault prolapse repair when rendered
    • S759A - Hysterectomy - with or without adnexa (unless otherwise specified) – with anterior or posterior vaginal repair and including enterocoele and/or vault prolapse repair when rendered
    • S762A - Hysterectomy - with or without adnexa (unless otherwise specified) – radical trachelectomy - excluding node dissection
    • S763A - Hysterectomy - with or without adnexa (unless otherwise specified) – radical (Wertheim or Schauta) - includes node dissection
    • S765A – Amputation of cervix
    • S766A- Cervix uteri - Exc - cervical stump – abdominal
    • S767A- Cervix uteri - exc - Cervical stump – vaginal
    • S816A - Hysterectomy - with or without adnexa (unless otherwise specified) - vaginal

Data Source
Ontario Cancer Registry (OCR), Ontario Health Insurance Plan (OHIP) Claims History Database, PCCF+ version 5k6A, Registered Persons Database (RPDB)
Data provided to HQO by
Local data collection
 
OTHER RELEVANT INFORMATION
Comments Detailed
This is an additional indicator for QIP 2018/19 Current performance reporting period: Annually How to access the data: Primary data source is EMR. Organizations may also find it helpful to consult their physicians' CCO SAR reports' to validate the data from their EMR. To enrol to receive SAR, click here. Cancer Care Ontario offers Healthcare Provider Resources - Cervical Screening The Screening Activity Report (SAR) provides patient enrolment model (PEM) primary care doctors with a supplementary tool for improving their cancer screening rates and appropriate follow-up for breast, cervical and colorectal cancer screening. The information in the SAR are updated on the 10th calendar day every month to provide timely breast, cervical and colorectal cancer screening data. This indicator is consistent with Cancer Care Ontario’s cervical cancer screening indicator included on Cancer System Quality Index (CSQI) website http://www.csqi.on.ca/. For the detailed methodology, please refer to Cervical Screening Participation. Please note that QIP rate is not risk adjusted.
 
TAGS
Sector
Primary Care
Type
Outcome
Topic
Prevention / Screening
Dimension
Equitable
Source
Ontario Cancer Registry (OCR), Ontario Health Insurance Plan (OHIP) Claims History Database, PCCF+ version 5k6A, Registered Persons Database (RPDB)
 
PUBLISH
Publish Datetime
04/03/2019 10:14:00